AusAm Biotechnologies Inc.
www.ausambiotech.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From AusAm Biotechnologies Inc.
Start-Up Previews (12/03)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Therapeutic Antibodies, features profiles of Acceptys Inc., KaloBios Inc. and Rinat Neuroscience Corp. Plus these Start-Ups Across Health Care: Atritech Inc, AusAm Biotechnologies Inc., Cenix BioScience GMBH and TransOral Pharmaceuticals Inc.
AusAm Biotechnologies Inc.
Three-year-old AusAm Biotechnologies is actively pursuing both diagnostics and therapeutics, with all novel technologies based on its founding scientists' observations about the kidney. In diagnostics, it recently received FDA clearance for a highly sensitive test that detects precursors to kidney disease. The test has potential to become a wide screen, particularly for at-risk diabetics. In therapeutics, it is developing a polysaccharide-based class of anti-viral attachment inhibitors, which have potential in treatment of infectious diseases like AIDs, encephalitis and small pox.
Company Information
- Industry
- Biotechnology
- In Vitro Diagnostics
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice